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Objectives: To clarify the association between
glucose intolerance and high altitudes (2900–4800 m)
in a hypoxic environment in Tibetan highlanders and to
verify the hypothesis that high altitude dwelling
increases vulnerability to diabetes mellitus (DM)
accelerated by lifestyle change or ageing.
Design: Cross-sectional epidemiological study on
Tibetan highlanders.
Participants: We enrolled 1258 participants aged 40–
87 years. The rural population comprised farmers in
Domkhar (altitude 2900–3800 m) and nomads in
Haiyan (3000–3100 m), Ryuho (4400 m) and
Changthang (4300–4800 m). Urban area participants
were from Leh (3300 m) and Jiegu (3700 m).
Main outcome measure: Participants were
classified into six glucose tolerance-based groups: DM,
intermediate hyperglycaemia (IHG), normoglycaemia
(NG), fasting DM, fasting IHG and fasting NG.
Prevalence of glucose intolerance was compared in
farmers, nomads and urban dwellers. Effects of
dwelling at high altitude or hypoxia on glucose
intolerance were analysed with the confounding factors
of age, sex, obesity, lipids, haemoglobin, hypertension
and lifestyle, using multiple logistic regression.
Results: The prevalence of DM (fasting DM)/IHG
(fasting IHG) was 8.9% (6.5%)/25.1% (12.7%),
respectively, in all participants. This prevalence was
higher in urban dwellers (9.5% (7.1%)/28.5%
(11.7%)) and in farmers (8.5% (6.1%)/28.5%
(18.3%)) compared with nomads (8.2% (5.7%)/15.7%
(9.7%)) (p=0.0140/0.0001). Dwelling at high altitude
was significantly associated with fasting IHG+fasting
DM/fasting DM (ORs for >4500 and 3500–4499 m
were 3.59/4.36 and 2.07/1.76 vs <3500 m,
respectively). After adjusting for lifestyle change,
hypoxaemia and polycythaemia were closely associated
with glucose intolerance.
Conclusions: Socioeconomic factors, hypoxaemia
and the effects of altitudes >3500 m play a major role
in the high prevalence of glucose intolerance in
highlanders. Tibetan highlanders may be vulnerable to
glucose intolerance, with polycythaemia as a sign of
poor hypoxic adaptation, accelerated by lifestyle
change and ageing.
INTRODUCTION
Over many generations, people living at high
altitudes have developed unique practices to
survive in challenging environments with
Strengths and limitations of this study
▪ The study showed the first evidence of a close
association of glucose intolerance with dwelling
at high altitude over 3500 m or hypoxaemia after
adjustment of lifestyle-related factors.
▪ The study also showed the vulnerability of
glucose intolerance in high-altitude people with
adaptation to hypoxia accelerated by ageing and
lifestyle change. In addition, this study used vali-
dated POC (point-of-care) analysers for blood
glucose and haemoglobin measurement that
were not affected by the high-altitude
environment.
▪ Farmers and nomads could be analysed in differ-
ent altitudes as almost homogeneous subjects.
But urban dwellers, who had changed to a mod-
ernised lifestyle, were analysed at different alti-
tudes, which was not homogeneous. Multiple
logistic regression analysis was used for adjust-
ing lifestyle and other confounding factors.
▪ It is a cross-sectional study and, thus, requires a
future longitudinal study to disclose any causal
relations. Also, the genes involved in adaptation
to hypoxia were not examined. The study did not
investigate whether nutrition and physical activ-
ities were confounding factors to glucose intoler-
ance, but measuring body mass index and
dyslipidaemia may reflect those effects.
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limited ecological resources.1–3 Traditionally, diabetes
mellitus (DM) has been uncommon among highlan-
ders4 5 compared with lowlanders.6 7 Lifestyle-related dis-
eases, such as DM and hypertension, are rapidly
increasing with an increase in longevity and changes in
lifestyle worldwide. A remarkable increase in DM has
been reported in lowlander and semi-high altitude
(around 1300 m) migrants who moved from traditional
lifestyles to Westernised lifestyles.8–10 Prevention of DM
has become an urgent issue among lowlanders, espe-
cially in developing countries, where the rate of DM
prevalence is much faster than in developed coun-
tries.11 12 Older people with a low economic status in
rural areas might be vulnerable to impaired glucose tol-
erance or DM in developed and developing coun-
tries.13 14 An adverse intrauterine environment is a risk
factor of diabetes,15 and there is an association between
low birth weight and type 2 diabetes.16 These phenom-
ena all show adaptation to a low-caloric intake, and the
rapid change to a high intake likely increases the risk of
diabetes, possibly through a mechanism related to
epigenetics.17 18
People living at high altitudes not only have the previ-
ously mentioned risk factors, but they are also subject to
hypoxia in a severe natural environment.19 High-altitude
dwellers show long-term adaptation to harsh
environment-induced hypoxia. Highlanders are biologic-
ally adapted to hypoxic environments by various genetic
mechanisms, such as an increase in haemoglobin con-
centrations or increased blood ﬂow without polycythae-
mia.20 21 Andean people have increased haemoglobin
levels as a result of hypoxic adaptation, but they suffer
from chronic mountain sickness with excessive polycy-
thaemia as a maladaptation to hypoxia more often than
Tibetan people do.22 Ageing, menopause, respiratory
disorders, obesity and hypertension are risk factors of
chronic mountain sickness.23–26 As a result of rapid life-
style changes related to urbanisation, highlanders are
experiencing an alarming increase in diabetes.27–30
Tibetan residents, especially those who are obese, may
be more vulnerable to glucose intolerance31 compared
with Andean people.5 32 Whether high-altitude dwellers
are more vulnerable to diabetes as a result of lifestyle
changes, compared with lowlanders, is unknown, but
people living at high altitudes are known to be vulner-
able to hypertension.4 33–36
A population-based study of the effects of high alti-
tude, between 1200 and 3000 m, on the same ethnic
group, showed a low prevalence of impaired glucose
regulation at high altitudes.37 Also, an inverse associ-
ation has been shown between diabetes and altitudes
lower than 3500 m in lowlanders.38 Additionally, lowland
patients with diabetes show better glucose intolerance
improvement at a mildly high altitude.39 However, there
are no reports on whether dwelling at altitudes over
3500 m and hypoxaemia increases the risk of diabetes.
We previously reported a strong association between
glucose intolerance and polycythaemia in elderly
Tibetan people living in two highland areas.40 Because
they had adapted to hypoxia by reducing polycythaemia,
polycythaemia may be regarded as a sign of maladapta-
tion to hypoxia for Tibetan people.
The aim of this study was to clarify the association of
glucose intolerance with hypoxaemia or dwelling at alti-
tudes of 2900–4800 m in Tibetan highlanders, and to
verify the hypothesis that high-altitude dwelling in
Tibetan highlanders increases their vulnerability to DM
when accelerated by lifestyle change or ageing. This
hypothesis is based both on the current accelerated and
modernised lifestyle change occurring in middle-aged
and elderly highlanders coming from a traditional child-
hood lifestyle, and on the high prevalence of polycythae-




This cross-sectional epidemiological study was carried
out from 2008 to 2011. A total of 1258 participants aged
40–87 years (mean age±SD, 58.0±11.5 years) were exam-
ined. The study population consisted of consecutive
volunteers who attended our medical camps held in
three highland communities in China as follows: 86
Tibetan nomads (mean age, 66.7±5.3 years; male/
female: 40/46) living in a Tibetan nomadic village in
Haiyan County (altitude, 3000–3100 m) in 2008; 324
Tibetan urban residents (59.3±10.6 years; 127/197) in
Jiegu Town (3700 m) in 2009; and 41 Tibetan nomads
in Ryuho (4200–4400 m) in 2011 in Yushu County,
Qinghai (table 1).
Participants in three highland communities in Ladakh,
India, were examined as follows: 295 Ladakhi farmers
(57.3±12.0 years, 113/182) in Domkhar village (2900–
3800 m) in 2009; 308 urban residents (42 Ladakhi/266
Tibetan) (58.1±12.2 years, 126/182) in Leh Town
(3300 m) in 2010; and 204 nomads (126 Ladakhi/78
Tibetan) (54.4±10.9 years, 113/91) in six villages in
Changthang (4300–4800 m) in 2011. The participants
consisted of people aged 40 years or older, except for 86
participants in Haiyan who were elderly people aged
60 years or older. Announcements for recruitment were
carried out by health staff of Qinghai University and
health centres in a nomadic village in Haiyan, and in
two villages in Ryuho and Jiegu Town. Announcements
were also made to people aged 40 years or older by
health staff from Ladakh Institute of Prevention, from
health centres and from village leaders in the three vil-
lages in Domkhar, four villages in Changthang and ﬁve
colonies of migrants in Leh. We carried out health
checks of the volunteer participants in health centres or
community halls in rural villages or towns.
Haiyan County (population, 38 000) contains a
Tibetan nomadic village with 465 people aged 60 years
or older,41 42 who were all invited as volunteer partici-
pants for medical check-ups. Eighty-six agreed to take
2 Okumiya K, et al. BMJ Open 2016;6:e009728. doi:10.1136/bmjopen-2015-009728
Open Access
group.bmj.com on July 26, 2016 - Published by http://bmjopen.bmj.com/Downloaded from 
part. The study site in Haiyan County was located
between an agricultural area inhabited by Han Chinese
and a pastoral area inhabited by native Tibetans.43
Ryuho consists of six villages with a total population of
8700, including 1604 residents aged 40 years or older.44
People in two representative villages were invited to par-
ticipate in medical check-ups and 41 Tibetan nomads
agreed. Their lifestyle is difﬁcult because of the high alti-
tude and severe cold. They move from one pasture (alti-
tude approximately 4100 m) to another (approximately
5000 m) and back every 6 months, along with their
livestock.
Jiegu Town, with a population of 23 000, is the seat of
Yushu County (population, 67 000) in a nomadic area
of Qinghai on the Tibetan plateau. With socioeconomic
globalisation, this town is a rapidly developing area
(population in 1996, 6460).45 46 People aged 40 years or
older were randomly invited for medical check-ups and
324 of the urban Tibetan residents agreed to participate.
These participants had varied occupations, which
included being active or retired nomads, farmers or ofﬁ-
cial workers. They were considered to have a lifestyle
similar to city dwellers.
Domkhar in Ladakh is a rural village along the
Domkhar valley, which consists of the three communities
of Dho, Barma and Gongma, at altitudes of 2900, 3400
and 3800 m, respectively, with a total population of 1269
people, including 449 aged 40 years or older.47 All were
invited for medical check-ups, of whom 295 Ladakhi
farmers agreed to volunteer as participants in the survey.
The area was not easily accessible and Domkhar has only
begun to experience the effects of socioeconomic glo-
balisation in the past few years. Most residents were
active farmers with traditional lifestyles, who had experi-
enced changes in their food habits and received access
to electricity.
Since the 1970s, the residents of Leh Town have had a
history of migration from the Changthang area; they
comprise Tibetan as well as Ladakhi nomads. From four
representative colonies (population 1435), 637 people
aged 40 years or older were invited as volunteer partici-
pants for medical check-ups, and 308 of these urban
residents (266 Tibetans and 42 Ladakhis) agreed to par-
ticipate in the survey. They were included in the urban
population group because they were considered to have
adopted a lifestyle similar to that of city dwellers.
Changthang is the highest plateau (altitude 4300–
4800 m) among the regions included in this study. From
ﬁve representative villages (total population 1840), 491
people aged 40 years or older were invited for medical
check-ups and 204 nomads (78 Tibetans and 126
Ladakhis) voluntarily agreed to participate. This popula-
tion is generally made up of nomads who move with
their livestock from pasture to pasture every 3 months.
Their lifestyle is difﬁcult because of the high altitude
and severe cold.
Measurements
Anthropometric measurements, including weight and
height, were obtained using standard techniques. Body
mass index (BMI) was calculated as weight (kg)/height
(m2). Blood pressure was measured on the arm using an
automatic device (HEM 7000; Omron Life Science Co
Ltd, Kyoto, Japan) based on the cuff oscillometric prin-
ciple, and its accuracy has been validated in previous
studies.48 Oxyhaemoglobin saturation (SpO2) was mea-
sured by a pulse oximeter (PULSOX-300; Konica
Minolta Co Ltd, Tokyo, Japan). Blood pressure and
SpO2 were measured twice, in the sitting position, after
taking a 5 min rest, at least, and the mean systolic blood
pressure (SBP), diastolic blood pressure (DBP) and
SpO2 were calculated. Hypertension was deﬁned as SBP
≥140 mm Hg and/or DBP of ≥90 mm Hg and/or taking
current antihypertensive medicine.49
Overnight fasting venous samples were collected in
the morning from all participants. Blood glucose was
analysed in venous whole blood by a new-generation
StatStrip analyser (Nova Biomedical, Boston,
Massachusetts, USA), which has been validated as being
affected by neither haematocrit50–52 nor high altitude.53
Additionally, the StatStrip is as accurate for measuring
plasma glucose as a standard laboratory analyser is,50–52
although previous analysers were inﬂuenced by haem-
atocrit50–52 and high altitude.54 Haemoglobin (Hb) was
analysed by the Hemocue haemoglobinometer
(Hemocue, Angelholm, Sweden).55 56 Samples were ana-
lysed at 15–25°C. Lipids were analysed by either a
central laboratory in Qinghai University Hospital, China,
or at SRL Inc, India.
Stages of glucose tolerance were classiﬁed into either
normoglycaemia (NG) or hyperglycaemia (HG) by an
oral glucose tolerance test (OGTT) according to WHO
Table 1 Characteristics of the field sites in high-altitude regions
Rural/urban Area Altitude (m above MSL) n (male/female) Livelihood
Rural Domkhar in Ladakh 2900–3800 295 (113/182) Farmer
Changthang in Ladakh 4300–4800 204 (113/91) Livestock-rearing nomads
Haiyan in Qinghai 3000–3100 86 (40/46) Livestock-rearing nomads
Ryuho in Qinghai 4200–4400 41 (22/19) Livestock-rearing nomads
Urban Leh Town in Ladakh 3300 308 (126/182) Urban lifestyle
Jiegu Town in Yushu, Qinghai 3700 324 (127/197) Urban lifestyle
MSL, mean sea level.
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criteria. The presence of HG consisting of DM and inter-
mediate HG (IHG) was deﬁned as follows: DM was
fasting blood glucose (FBG) levels ≥7.0 mmol/L or 2 h
blood glucose levels of ≥11.1 mmol/L, and IHG was
fasting glucose levels ≥6.1 mmol/L and <7.0 mmol/L or
2 h glucose levels ≥7.8 mmol/L and <11.1 mmol/L.
Fasting NG and fasting HG were deﬁned using only FBG
results. Fasting HG consisted of fasting IHG (FBG levels
≥6.1 and <7.0 mmol/L) and fasting DM (FBG levels
≥7.0 mmol/L).57
Overweight was deﬁned as a BMI of 25 or over.
Dyslipidaemia was deﬁned as triglycerides >150 mg/dL,
total cholesterol >220 mg/dL and/or high-density lipo-
protein (HDL) cholesterol <40 mg/dL. Hypoxaemia was
deﬁned as SpO2 <89 mm Hg. Levels of Hb were classiﬁed
into four groups: anaemia (Hb <13 g/dL for males and
<12 g/dL for females), normal (Hb <18 and ≥13 g/dL
for males and Hb <16 and ≥12 g/dL for females), mod-
erate polycythaemia (Hb <21 and ≥18 g/dL for males
and Hb <19 and ≥16 g/dL for females) and excessive
polycythaemia (Hb ≥21 g/dL for males and ≥19 g/dL
for females).
Levels of glycated Hb (HbA1c) based on the National
Glycohemoglobin Standardization Program (NGSP)
were analysed by Latex agglutination immunoassay (DCA
2000 HbA1c, Siemens Healthcare Co Ltd, Munich,
Germany) in 949 participants in all the ﬁeld sites except
for participants in Haiyan. The frequencies of HbA1c
levels ≥6.0% and ≥6.5% were compared among the dif-
ferent classiﬁcations of glucose intolerance.
The age of the participants was conﬁrmed with refer-
ence to carefully prepared cross-tabulation correlating
their date of birth with the animal year, which the rural
population always remembered, and with historical senti-
nel events in the case of elderly participants. The inter-
viewers asked participants whether they currently or
previously smoked or currently drank alcohol.
Statistics
The χ2 test, Student t test and one-way analysis of vari-
ance (ANOVA) were conducted to analyse: the rate of
prevalence of glucose intolerance, hypertension, over-
weight, hypoxaemia, dyslipidaemia, anaemia and polycy-
thaemia; altitude level, dwelling area and livelihood;
mean blood glucose, SBP, DBP, BMI, SpO2, lipids and
Hb levels. The associations of glucose intolerance with
the confounding factors, including altitude, hypox-
aemia, age, sex, overweight, dyslipidaemia and liveli-
hood, were analysed by multiple logistic regression
analysis. Analyses were performed using SPSS V.17.0
(SPSS Inc, Chicago, Illinois, USA). A p value <0.05 was
considered statistically signiﬁcant.
RESULTS
The characteristics of all of the studied variables and the
differences by sex are shown in table 2. Male partici-
pants were older with a lower prevalence of overweight
than female participants. They also had a higher preva-
lence of IHG/fasting IHG, DM/fasting DM, high trigly-
ceride levels, low HDL levels and dyslipidaemia,
excessive polycythaemia and a lower prevalence of
anaemia than female participants. In addition, male par-
ticipants were more prevalent at altitudes over 4500 m
and as nomads than female participants, but females
were more prevalent as farmers and urban dwellers. The
prevalence of current or past smokers was 4.7% (males
9.4% and females 1.1%). The prevalence of current
alcohol drinkers was 25.4% (males 35.7% and females
17.6%).
The characteristics of all the studied variables by dif-
ference in age are shown in table 3. Male participants
were more prevalent at age 70 years or older. The preva-
lence of dyslipidaemia and hypertension was higher in
older participants. Older people were also more preva-
lent as urban dwellers, but less prevalent in dwelling
over 4500 m. Prevalence of hypoxaemia (SpO2 <89%)
was higher in older participants, but not for anaemia
and excessive polycythaemia.
Table 4 shows the association of glucose intolerance
(fasting IHG/fasting DM or IHG/DM), using the cri-
teria of FBG and OGTT, with all of the studied vari-
ables. Glucose intolerance increased with age. Glucose
intolerance was also associated with male sex, over-
weight, dyslipidaemia, hypertension, hypoxaemia, high
Hb levels, high HbA1c levels, high altitude and urban
dwellers/farmers (vs nomads). Neither smoking
nor drinking alcohol was associated with glucose
intolerance.
The prevalence of glucose intolerance, overweight,
dyslipidaemia, hypertension, hypoxaemia and polycy-
thaemia are shown at different altitude areas in
farmers, nomads and urban dwellers (table 5). In
farmers, the prevalence of fasting HG using the FBG
criterion was signiﬁcantly increased with elevation of
altitude (2900, 3400 and 3800 m) in the three commu-
nities of Dho, Barma and Gongma (n=106 (16.0%), 74
(20.3%), 115 (34.8%), respectively, p=0.0033) in
Domkhar, Ladakh. The prevalence of HG, using the
OGTT criterion in the three communities, was also
increased (30.2%, 36.5%, 43.5%, respectively), but not
signiﬁcantly. In comparison, between the two altitude
levels of <3500 m (Dho and Barma) and ≥3500 m
(Gongma), the prevalence of glucose intolerance using
the FBG criterion was signiﬁcantly increased with eleva-
tion of altitude (fasting HG: 17.8% vs 34.8%, fasting
DM: 3.3% vs 10.4%, HbA1c >6.0%: 15.5% vs 29.9%) in
spite of the low prevalence of overweight people dwell-
ing at a higher altitude compared with those at a lower
altitude (table 5).
A comparison of nomad participants was conducted
between Haiyan and Ryuho in Qinghai, and the preva-
lence of fasting HG using the FBG criterion was found
to increase, but not signiﬁcantly (8.1% vs 12.2%) with
elevation of altitude (3000–3100 vs 4200–4400 m).
In Changthang-1 and Changthang-2 in Ladakh, the
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Table 2 Characteristics of the studied variables by sex
All Male Female p Value
N 1258 541 717
(%) 43.0 (40.3 to 45.7) 57.0 (54.3 to 59.7)
Age (years) 58.0±11.5 58.9±11.8 57.3±11.2 0.0120
Height (cm) 157.4±9.4 163.9±8.1 152.4±7.0 <0.0001
Weight (kg) 60.8±13.9 64.8±13.1 57.8±13.7 <0.0001
BMI 24.4±4.5 24.0±4.1 24.7±4.9 0.0064
Overweight (BMI>25) (%) 40.1 (37.4 to 42.8) 36.6 (32.5 to 40.7) 42.8 (39.2 to 46.4) 0.0259
Blood glucose
FBG (mg/dL) 101.3±24.5 104.7±29.6 98.7±19.5 <0.0001
2 h-BG (mg/dL) 124.9±50.1 129.3±58.6 121.6±42.3 0.0068
Fasting IHG/Fasting DM (%) 12.7 (10.9 to 14.5)/6.5 (5.1 to 7.9) 15.3 (12.3 to 18.3)/9.6 (7.1 to 12.1) 10.7 (8.4 to 13.0)/4.2 (2.7 to 5.7) <0.0001
IHG/DM (%) 25.1 (22.7 to 27.5)/8.9 (7.3 to 10.5) 27.5 (23.7 to 31.3)/12.0 (9.3 to 14.7) 23.3 (20.2 to 26.4)/6.6 (4.8 to 8.4) 0.0002
Dyslipidaemia 34.8 (32.2 to 37.4) 38.3 (34.2 to 42.4) 32.2 (28.3 to 36.1) 0.0259
Triglycerides 98.5±58.3 104.8±56.5 93.7±59.3 0.0012
Triglycerides ≥150 mg/dL (%) 12.3 (10.5 to 14.1) 16.0 (12.9 to 19.1) 9.6 (7.1 to 12.1) 0.0011
Total cholesterol 187.3±46.2 185.5±45.2 188.4±47.4 NS
Total cholesterol ≥220 mg/dL (%) 21.9 (19.6 to 24.2) 20.1 (16.7 to 23.5) 23.3 (20.2 to 26.4) NS
HDL cholesterol 52.6±16.2 50.7±20.2 54.1±12.0 0.0003
HDL cholesterol<40 mg/dL (%) 13.8 (11.9 to 15.7) 19.3 (16.0 to 22.6) 9.6 (7.4 to 11.8) <0.0001
SBP (mm HG) 134.0±25.1 135.6±23.4 132.8±26.3 0.0507
DBP (mm HG) 85.6±14.4 86.0±14.2 85.2±14.5 NS
Hypertension (%) 40.4 (37.7 to 43.1) 42.7 (38.5 to 46.9) 38.7 (35.1 to 42.3) NS
Livelihood
Farmer (%) 23.5 (21.2 to 25.8) 20.9 (17.5 to 24.3) 25.4 (22.2 to 28.6) 0.0001
Nomad (%) 26.3 (23.9 to 28.7) 32.3 (28.4 to 36.2) 21.8 (18.8 to 24.8)
Urban dweller (%) 50.2 (47.4 to 53.0) 46.8 (42.6 to 51.0) 52.9 (49.2 to 56.6)
Altitude (m) 3641.7±523.3 3691.7±562.3 3603.9±488.9 0.0032
Altitude level (%)
2500–3499 m 45.6 (42.8 to 48.4) 44.4 (40.2 to 48.6) 46.6 (42.9 to 50.3 0.0002
3500–4499 m 41.9 (39.2 to 44.6) 38.8 (34.7 to 42.9) 44.2 (40.6 to 47.8)
4500+ m 12.5 (10.7 to 14.3) 16.8 (13.6 to 20.0) 9.2 (7.1 to 11.3)
SpO2 (%) 90.6±4.3 90.8±4.1 90.5±4.4 NS
Hypoxaemia (SpO2 <89%) (%) 25.2 (22.8 to 27.6) 25.0 (21.4 to 28.6) 25.4 (22.2 to 28.6) NS
Hb (g/dL) 15.6±2.7 17.1±2.3 14.5±2.4 <0.0001
Group according to Hb (%)
Anaemia 7.5 (6.0 to 9.0) 2.0 (0.8 to 3.2) 11.6 (9.3 to 13.9) <0.0001
Normal 56.4 (53.7 to 59.1) 59.3 (55.2 to 63.4) 54.3 (50.7 to 57.9)
Moderate polycythaemia 27.7 (25.2 to 30.2) 24.8 (21.2 to 28.4) 29.8 (26.5 to 33.1)
Excessive polycythaemia 8.4 (6.9 to 9.9) 13.9 (11.0 to 16.8) 4.3 (2.8 to 5.8)
Values are mean±SD, or % (95% CI).
Data were analysed using χ2 test for comparison of the rates of variables, and by the Student t test for comparison of variables between males and females.
2h-BG, 2 h blood glucose following 75 g OGTT; BMI, body mass index; DBP, diastolic blood pressure; DM, diabetes mellitus by OGTT; fasting DM, fasting diabetes mellitus by FBG; fasting
IHG, fasting intermediate hyperglycaemia by FBG; FBG, fasting blood glucose; Hb, haemoglobin; HDL, high-density lipoprotein; NS, not significant; OGTT, oral glucose tolerance test; SBP,




























prevalence of fasting HG using FBG criterion increased
(12.8% vs 21.0%) with elevation of altitude (4300–4400
vs 4500–4800 m), but not signiﬁcantly, while the preva-
lence of fasting DM signiﬁcantly increased (0.0% vs
8.9%, p=0.0339). Comparing the three altitude levels,
<3500 (Haiyan), 3500–4499 (Ryuho and Changthang-1)
and ≥4500 m (Changthang-2), the prevalence of
glucose intolerance with the FBG criterion was signiﬁ-
cantly increased with elevation of altitude (fasting HG:
8.1% (Haiyan) vs 12.5% (Ryuho and Changthang-1) vs
21.0% (Changthan-2), fasting DM: 3.5% vs 2.3% vs
8.9%) despite the low prevalence of overweight and dys-
lipidaemia in people dwelling at a higher altitude than
at a lower altitude (table 5).
In urban dwellers, using both criteria to measure
fasting HG, fasting DM, HG, DM and HbA1c, showed
that the prevalence of glucose intolerance increased sig-
niﬁcantly with elevation of altitude (table 5). The results
also indicated a greater prevalence of overweight and
hyperlipidaemia in people dwelling at a higher altitude
than in those at a lower altitude. Prevalence of hyperten-
sion was not associated with altitude levels in farmers,
nomads and urban dwellers.
Prevalence of hypoxaemia and polycythaemia was sig-
niﬁcantly increased with elevation of altitude in all the
groups of farmers, nomads and urban dwellers.
The association of the variables Hb, overweight and
glucose intolerance, with hypoxaemia (SpO2 <89%) as
the dependent variable, was separately analysed after
adjustment for age, sex and altitude levels, using mul-
tiple logistic regression (models 1–3). Polycythaemia
(model 1), overweight (models 2 and 3), fasting HG
(model 2), fasting DM (OR=1.70, CI 1.02 to 2.85, vs no
fasting DM, p=0.0413), HG (model 3) and DM
(OR=1.90, CI 1.21 to 2.96, vs no DM, P=0.0049) were
associated with hypoxaemia independent of altitude
levels (see online supplementary table S1).
The variables that were associated with glucose intoler-
ance and adjusted for age and sex in the four models
(for dependent variables of fasting HG, fasting DM, HG
and DM) by multiple logistic regression analysis are
shown in table 6. Overweight (all models), hypoxaemia
(all models), dyslipidaemia (all models), polycythaemia
(all models), farmers (models for fasting HG and for
HG, vs nomads) and urban dwellers (models for HG vs
nomads) were associated with glucose intolerance after
adjustment for age and sex. Altitude level of 3500–
4499 m was closely associated with all models, while the
highest level of ≥4500 m was associated with fasting HG
and fasting DM, but not with HG or DM. By classifying
the altitude level into two groups of 2500–3499 and
≥3500 m and analysing by multiple logistic regression,
the altitude level of ≥3500 m was closely associated with
glucose intolerance in all the models compared with
2500–3499 m altitude.
The associations of high altitude, hypoxaemia and
polycythaemia with glucose intolerance and adjusted for
related variables in the four models were analysed by
Table 3 Characteristics of the studied variables by age
Age (years) p Value
40–49 50–59 60–69 70+
N 354 287 384 233
Male (vs female) (%) 42.1 (37.0 to 47.2) 38.3 (32.7 to 43.9) 41.9 (37.0 to 46.8) 51.9 (45.5 to 58.3) 0.0152
Overweight (BMI≥25) (%) 39.8 (34.7 to 44.9) 38.0 (32.4 to 43.6) 42.7 (37.8 to 47.6) 39.1 (32.8 to 45.4) NS
Dyslipidaemia (%) 29.1 (24.4 to 33.8) 30.7 (25.4 to 36.0) 42.7 (37.0 to 48.4) 35.6 (30.1 to 41.1) 0.0005
Triglycerides ≥150 mg/dL 10.7 (7.5 to 13.9) 13.3 (9.4 to 17.2) 14.2 (10.7 to 17.7) 10.8 (6.8 to 14.8) NS
Total cholesterol ≥220 mg/dL 12.4 (9.0 to 15.8) 16.1 (11.8 to 20.4) 34.6 (29.8 to 39.4) 24.1 (18.6 to 29.6) <0.0001
HDL cholesterol <40 mg/dL 17.9 (13.9 to 21.9) 10.7 (7.1 to 14.3) 11.3 (8.1 to 14.5) 15.1 (10.5 to 19.7) 0.0259
Hypertension (%) 23.4 (19.0 to 27.8) 39.0 (33.4 to 44.6) 44.8 (39.8 to 49.8) 61.0 (54.7 to 67.3) <0.0001
Livelihood (%)
Farmer 25.1 (20.6 to 29.6) 28.6 (23.4 to 33.8) 18.8 (14.9 to 22.7) 22.3 (17.0 to 7.6) 0.0125
Nomad 29.4 (24.7 to 34.1) 23.7 (18.8 to 28.6) 28.4 (23.9 to 32.9) 21.5 (16.2 to 26.8)
Urban dweller 45.5 (40.3 to 50.7) 47.7 (41.9 to 53.5) 52.9 (47.9 to 57.9) 56.2 (49.8 to 62.6)
Altitude level (%)
2500–3499 m 41.5 (36.4 to 46.6) 46.3 (40.5 to 52.1) 43.5 (38.5 to 48.5) 54.5 (48.1 to 60.9) <0.0001
3500–4499 m 42.1 (37.0 to 47.2) 36.9 (31.3 to 42.5) 47.1 (42.1 to 52.1) 39.1 (32.8 to 45.4)
4500+ m 16.4 (12.5 to 20.3) 16.7 (12.4 to 21.0) 9.4 (6.5 to 12.3) 6.4 (3.3 to 9.5)
Hypoxaemia
SpO2 <89% (%) 20.1 (15.9 to 24.3) 23.7 (18.8 to 28.6) 26.3 (21.9 to 30.7) 33.0 (27.0 to 39.0) 0.0043
Group according to Hb (%)
Anaemia 13.3 (9.8 to 16.8) 5.2 (2.6 to 7.8) 4.7 (2.6 to 6.8) 6.0 (3.0 to 9.0) <0.0001
Normal 49.4 (44.2 to 54.6) 54.4 (48.6 to 60.2) 59.9 (55.0 to 64.8) 63.9 (57.7 to 70.1)
Polycythaemia 24.9 (20.4 to 29.4) 31.0 (25.6 to 36.4) 29.9 (25.3 to 34.5) 24.0 (18.5 to 29.5)
Excessive polycythaemia 12.4 (9.0 to 15.8) 9.4 (6.0 to 12.8) 5.5 (3.2 to 7.8) 6.0 (3.0 to 9.0)
Values are % (95% CI).
BMI, body mass index; Hb, haemoglobin; HDL, high-density lipoprotein; SpO2, oxyhaemoglobin saturation measured by pulse oximeter.
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Table 4 Variables associated with glucose intolerance
By FBG By OGTT
All Fasting NG Fasting IHG Fasting DM p Value NG IHG DM p Value
N 1258 1016 160 82 830 316 112
% 80.8 (78.6 to 83.0) 12.7 (10.9 to 14.5) 6.5 (5.1 to 7.9) 66.3 (63.7 to 68.9) 24.9 (22.5 to 27.3) 8.8 (7.2 to 10.4)
Sex n (%) (%) (%) (%) (%) (%)
Male 541 75.0 (71.4 to 78.6) 15.3 (12.3 to 18.3) 9.6 (7.1 to 12.1) <0.0001 60.4 (56.3 to 64.5) 27.5 (23.7 to 31.1) 12.0 (9.3 to 14.7) 0.0002
Female 717 85.1 (82.5 to 87.7) 10.7 (8.4 to 13.0) 4.2 (2.7 to 5.7) <0.0001 70.2 (66.9 to 73.5) 23.3 (20.2 to 26.4) 6.6 (4.8 to 8.4)
Age (years) n (%) (%) (%) 0.1012 (%) (%) (%) 0.0005
40–49 354 84.7 (80.9 to 88.5) 10.5 (7.3 to 13.7) 4.8 (2.6 to 7.0) 72.6 (68.0 to 77.2) 21.8 (17.5 to 26.1) 5.7 (3.3 to 8.1)
50–59 287 82.2 (77.8 to 86.6) 11.2 (7.6 to 14.8) 6.6 (3.7 to 9.5) 70.7 (65.4 to 76.0) 20.2 (15.6 to 24.8) 9.1 (5.8 to 12.4)
60–69 384 75.8 (71.5 to 80.1) 15.9 (12.2 to 19.6) 8.3 (5.5 to 11.1) 60.9 (56.0 to 65.8) 27.6 (23.1 to 32.1) 11.5 (8.3 to 14.7)
70+ 233 81.1 (76.1 to 86.1) 12.9 (8.6 to 17.2) 6.0 (3.0 to 9.0) 58.4 (52.1 to 64.7) 32.2 (26.2 to 38.2) 9.4 (5.7 to 13.1)
BMI n (%) (%) (%) (%) (%) (%)
Normal 753 84.1 (81.5 to 86.7) 11.0 (8.8 to 13.2) 4.9 (3.4 to 6.4) 0.0008 72.0 (68.8 to 75.2) 21.4 (18.5 to 24.3) 6.6 (4.8 to 8.4) <0.0001
Overweight (BMI
≥25%)
505 75.8 (72.1 to 79.5) 15.2 (12.1 to 18.3) 8.9 (6.4 to 11.4) 57.0 (52.7 to 61.3) 30.7 (26.7 to 34.7) 12.3 (9.4 to 15.2)
Dyslipidaemia n (%) (%) (%) (%) (%) (%)
Normal 820 84.1 (81.6 to 86.6) 11.5 (9.3 to 13.7) 4.4 (3.0 to 5.8) <0.0001 70.0 (66.9 to 73.1) 24.3 (21.4 to 27.2) 5.7 (4.1 to 7.3) <0.0001
Dyslipidaemia 438 74.4 (70.3 to 78.5) 15.1 (11.7 to 18.5) 10.5 (7.6 to 13.4) 58.4 (53.8 to 63.0) 26.7 (22.6 to 30.8) 14.8 (11.5 to 18.1)
Blood pressure n (%) (%) (%) (%) (%) (%)
Normal 749 83.3 (80.6 to 86.0) 11.5 (9.2 to 13.8) 5.2 (3.6 to 6.8) 0.0220 70.9 (67.6 to 74.2) 22.3 (19.3 to 25.3) 6.8 (5.0 to 8.6) <0.0001
Hypertension 509 77.4 (73.8 to 81.0) 14.3 (11.3 to 17.3) 8.3 (5.9 to 10.7) 59.1 (54.8 to 63.4) 29.3 (25.3 to 33.3) 11.6 (8.8 to 14.4)
Livelihood n (%) (%) (%) (%) (%) (%)
Farmer 295 75.6 (70.7 to 80.5) 18.3 (13.9 to 22.7) 6.1 (3.4 to 8.8) 0.0140 63.1 (57.6 to 68.6) 28.5 (23.3 to 33.7) 8.5 (5.3 to 11.7) 0.0001
Nomad 331 84.6 (80.7 to 88.5) 9.7 (6.5 to 12.9) 5.7 (3.2 to 8.2) 76.1 (71.5 to 80.7) 15.7 (11.8 to 19.6) 8.2 (5.2 to 11.2)
Urban dweller 632 81.2 (78.2 to 84.2) 11.7 (9.2 to 14.2) 7.1 (5.1 to 9.1) 62.0 (58.2 to 65.8) 28.5 (25.0 to 32.0) 9.5 (7.2 to 11.8)
Altitude level (m) n (%) (%) (%) (%) (%) (%)
2500–3499 574 88.3 (85.7 to 90.9) 8.5 (6.2 to 10.8) 3.1 (1.7 to 4.5) <0.0001 70.7 (67.0 to 74.4) 23.2 (19.7 to 26.7) 6.1 (4.1 to 8.1) <0.0001
3500–4499 527 73.1 (69.5 to 76.7) 17.5 (14.4 to 20.6) 9.5 (7.1 to 11.9) 58.1 (54.1 to 62.1) 30.2 (26.4 to 34.0) 11.8 (9.2 to 14.4)
4500+ 157 79.0 (72.6 to 85.4) 12.1 (7.0 to 17.2) 8.9 (4.4 to 13.4) 75.2 (68.4 to 82.0) 15.3 (9.7 to 20.9) 9.6 (5.0 to 14.2)
SpO2 n (%) (%) (%) (%) (%) (%)
Normal 941 83.2 (80.8 to 85.6) 11.5 (9.5 to 13.5) 5.3 (3.9 to 6.7) 0.0004 68.2 (65.2 to 71.2) 24.4 (21.7 to 27.1) 7.3 (5.6 to 9.0) 0.0010
Hypoxaemia
(SpO2 <89%)
317 73.5 (68.6 to 78.4) 16.4 (12.3 to 20.5) 10.1 (6.8 to 13.4) 59.3 (53.9 to 64.7) 27.1 (22.2 to 32.0) 13.6 (9.8 to 17.4)
Group according
to Hb
n (%) (%) (%) (%) (%) (%)
Anaemia 94 86.2 (79.2 to 93.2) 11.7 (5.2 to 18.2) 2.1 (0 to 5.0) <0.0001 73.4 (64.5 to 82.3) 23.4 (14.8 to 32.0) 3.2 (0 to 6.8) <0.0001
Normal 710 86.3 (83.8 to 88.8) 10.1 (7.9 to 12.3) 3.5 (2.1 to 4.9) 71.3 (68.0 to 74.6) 23.2 (20.1 to 26.3) 5.5 (3.8 to 7.2)
Polycythaemia 348 73.3 (68.7 to 77.9) 16.4 (12.5 to 20.3) 10.3 (7.1 to 13.5) 57.5 (52.3 to 62.7) 29.0 (24.2 to 33.8) 13.5 (9.9 to 17.1)
Excessive
polycythaemia





























multiple logistic regression (table 7). For the dependent
variables of glucose intolerance (fasting HG/fasting
DM) as measured using the FBG criterion, the results
showed that dwelling at high altitudes was a closely asso-
ciated factor (ORs of fasting HG/fasting DM for >4500
and 3500–3999 m were 3.59/4.36 and 2.07/1.76 vs
<3500 m) independent of hypoxaemia and the
lifestyle-related factors of overweight and livelihood.
Classifying the altitude levels into two groups, 2500–3499
and ≥3500 m, and using multiple logistic regression ana-
lysis, the ≥3500 m altitude level was also closely asso-
ciated with fasting HG (OR=2.19, CI 1.53 to 3.12,
p<0.0001) and fasting DM (OR=1.94, CI 1.06 to 3.55,
p=0.0305), but not with HG and not with DM. For the
dependent variables of glucose intolerance (HG and
DM), using the OGTT criterion, there was no association
with dwelling at a high altitude, but hypoxaemia was a
closely associated factor. Polycythaemia, overweight, dysli-
pidaemia, farmers and urban dwellers were also closely
associated with glucose intolerance according to both
criteria. Hypertension was not associated with glucose
intolerance by multivariate analysis.
The effect of livelihood or ethnicity on the association
between altitudes and fasting HG was analysed and is
shown in online supplementary table S2. In models 1–3,
multivariate analyses were carried out separately in each
livelihood of farmer, nomad and urban dweller. In
farmers and nomads, higher altitude had signiﬁcantly
higher OR for fasting HG compared with lower altitude,
but not in urban dwellers after adjustment with other
confounding factors. In models 4 and 5, multivariate
analysis was carried out separately in each ethnic group,
Tibetan and Ladakhi. Higher altitude had signiﬁcantly
greater OR compared with lower altitude in both
groups. The OR was higher in the Ladakhi (2.53 vs
1.69) than in the Tibetan group. In models 6 and 7,
multivariate analysis was carried out in all participants,
and higher altitude had signiﬁcantly greater OR com-
pared with lower altitude independently of livelihood
and ethnicity (see online supplementary table S2).
DISCUSSION
Association of hypoxaemia with glucose intolerance
The association of glucose intolerance with
lifestyle-related health factors and hypoxaemia was
studied in 1258 residents dwelling at a wide range of alti-
tudes from 2900 to 4800 m in the Tibetan highland.
Previous studies have reported a negative association
between glucose intolerance and altitudes below 3500 m
in Tibetans37 and lowlanders.38 To the best of our knowl-
edge, we showed, for the ﬁrst time, epidemiological evi-
dence of a positive association between the prevalence
of fasting glucose intolerance at high altitudes over
3500 m and independently of hypoxaemia. These posi-
tive effects of dwelling at high altitudes were more dis-
tinct when glucose intolerance was deﬁned by FBG. The
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Table 5 Prevalence of glucose intolerance and other variables at different altitudes, in farmers, nomads and urban dwellers
Altitude (m above MSL)
2500–3499 m 3500–4499 m 4500+ m p Value
Farmer
Dho and Barma Gongma
(2900–3400 m) (3800 m)
n=180 n=115
Age 56.7±12.7 58.0±11.5 NS
Male (%) 41.3 (34.1 to 48.5) 33.9 (25.2 to 42.6) NS
Fasting hyperglycaemia (%) 17.8 (12.2 to 23.4) 34.8 (26.1 to 43.5) 0.0009
Fasting DM (%) 3.3 (0.7 to 5.9) 10.4 (4.8 to 16.0) 0.0129
Hyperglycaemia (%) 32.8 (25.9 to 39.7) 43.5 (34.4 to 52.6) 0.0633
DM (%) 7.2 (3.4 to 11.0) 10.4 (4.8 to 16.0) NS
Overweight (%) 21.7 (15.7 to 27.7) 11.3 (5.5 to 17.1) 0.0227
Dyslipidaemia (%) 16.7 (11.3 to 22.1) 17.4 (10.5 to 24.3) NS
Hypertension (%) 34.4 (27.5 to 41.3) 41.7 (32.7 to 50.7) NS
Hypoxaemia (%) 13.3 (8.3 to 18.3) 30.4 (22.0 to 38.8) 0.0004
Polycythaemia (moderate and excessive) (%) 18.4 (12.7 to 24.1) 35.6 (26.8 to 44.4) 0.0014
n=161 n=107





(3000–3100 m) (4100–4400 m) (4500–4800 m)
n=86 n=88 n=157
Age 66.7±5.3 52.6±10.8 54.5±10.5 <0.0001
Male (%) 46.5 (36.0 to 57.0) 50.0 (39.6 to 60.4) 58.0 (50.3 to 65.7) NS
Fasting hyperglycaemia (%) 8.1 (2.3 to 13.8) 12.5 (5.6 to 19.4) 21.0 (14.6 to 27.4) 0.0197
Fasting DM (%) 3.5 (0 to 7.4) 2.3 (0 to 5.4) 8.9 (4.4 to 13.4) 0.0581
Hyperglycaemia (%) 20.9 (12.3 to 29.5) 25.0 (16.0 to 34.0) 24.8 (18.0 to 31.6) NS
DM (%) 8.1 (2.3 to 13.9) 5.7 (0.9 to 10.5) 9.6 (5.0 to 14.2) NS
Overweight (%) 40.7 (30.3 to 51.1) 40.9 (30.6 to 51.2) 19.7 (13.5 to 25.9) 0.0002
Dyslipidaemia (%) 59.3 (48.9 to 69.7) 45.5 (35.1 to 55.9) 26.1 (19.2 to 33.0) <0.0001
Hypertension (%) 34.9 (24.8 to 45.0) 23.9 (15.0 to 32.8) 24.8 (18.0 to 31.6) NS
Hypoxaemia (%) 25.6 (16.4 to 34.8) 36.2 (26.2 to 46.2) 63.7 (56.2 to 71.2) <0.0001
Polycythaemia (moderate and excessive) (%) 36.1 (25.9 to 46.3) 64.7 (54.7 to 74.7) 64.3 (56.8 to 71.8) 0.0016
n=73 n=118
HbA1c ≥6.0% (%) – 24.7 (14.8 to 34.6) 26.3 (18.4 to 34.2) NS
Urban dweller
Leh Town, Ladakh Yushu, Qinghai
(3300 m) (3700 m)
n=308 n=324
Age 58.1±12.2 59.3±10.6 NS
Male (%) 40.9 39.2 NS
Fasting hyperglycaemia (%) 9.1 (5.9 to 12.3) 28.1 (23.2 to 33.0) <0.0001
Fasting DM (%) 2.9 (1.0 to 4.8) 11.1 (7.7 to 14.5) <0.0001
Hyperglycaemia (%) 29.5 (24.4 to 34.6) 46.0 (40.6 to 51.4) <0.0001
DM (%) 4.9 (2.5 to 7.3) 13.9 (10.1 to 17.7) 0.0001
Overweight (%) 42.9 (37.4 to 48.4) 67.6 (62.5 to 72.7) <0.0001
Dyslipidaemia (%) 24.0 (19.2 to 28.8) 56.2 (50.8 to 61.6) <0.0001
Hypertension (%) 48.1 (42.5 to 53.7) 49.4 (44.0 to 54.8) NS
Hypoxaemia (%) 8.4 (5.3 to 11.5) 27.8 (22.9 to 32.7) <0.0001
Polycythaemia (moderate and excessive) (%) 10.1 (6.7 to 13.5) 49.4 (44.0 to 54.8) <0.0001
n=305 n=185
HbA1c ≥6.0% (%) 22.3 (17.6 to 27.0) 41.6 (34.5 to 48.7) <0.0001
Values are mean±SD, n, or % (95% CI).
Data were analysed by the χ2 test for comparison of the rate of variables, or by the ANOVA for age among the different altitude groups.
ANOVA, analysis of variance; DM, diabetes mellitus; HbA1c, glycated haemoglobin; MSL, mean sea level; NS, not significant.
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Table 6 Variables associated with glucose intolerance adjusted for age and sex by multiple logistic regression analysis
Fasting hyperglycaemia Fasting DM Hyperglycaemia (OGTT) DM (OGTT)
OR CI p Value OR CI p Value OR CI p Value OR CI p Value
Age (years)
40–49 Reference Reference Reference Reference
50–59 1.20 (0.79 to 1.83) NS 1.41 (0.72 to 2.76) NS 1.10 (0.78 to 1.55) NS 1.66 (0.91 to 3.05) 0.0992
60–69 1.78 (1.22 to 2.58) 0.0025 1.80 (0.98 to 3.31) 0.0572 1.70 (1.25 to 2.32) 0.0008 2.16 (1.25 to 3.75) 0.006
70+ 1.29 (0.84 to 2.00) NS 1.27 (0.61 to 2.62) NS 1.89 (1.33 to 2.68) 0.0004 1.74 (0.93 to 3.27) 0.0843
Male (vs female) 1.90 (1.43 to 2.52) <0.0001 2.44 (1.54 to 3.89) 0.0002 1.54 (1.22 to 1.95) 0.0003 1.95 (1.31 to 2.89) 0.0009
Overweight (BMI
≥25)
1.77 (1.33 to 2.36) <0.0001 2.05 (1.30 to 3.23) 0.0022 2.02 (1.58 to 2.57) <0.0001 2.10 (1.41 to 3.12) 0.0003
Dyslipidaemia 1.70 (1.27 to 2.27) 0.0003 2.38 (1.50 to 3.76) 0.0002 1.56 (1.22 to 1.99) 0.0004 2.69 (1.80 to 4.01) <0.0001
Triglycerides
≥150




1.71 (1.22 to 2.38) 0.0018 2.49 (1.52 to 4.08) 0.0003 1.6 (1.19 to 2.14) 0.0017 2.88 (1.88 to 4.43) <0.0001
HDL
cholesterol <40
1.50 (1.01 to 2.23) 0.0441 1.70 (0.95 to 3.03) 0.0736 1.4 (0.99 to 1.98) 0.0579 1.39 (0.81 to 2.39) NS
Hypertension 1.40 (1.04 to 1.87) 0.0272 1.58 (0.99 to 2.52) 0.0544 1.53 (1.20 to 1.96) 0.0007 1.68 (1.12 to 2.52) 0.0128
Livelihood
Farmer 2.06 (1.37 to 3.11) 0.0005 1.24 (0.63 to 2.43) NS 2.10 (1.47 to 2.99) <0.0001 1.17 (0.66 to 2.07) NS
Nomad Reference Reference Reference Reference
Urban dweller 1.38 (0.96 to 2.00) 0.0817 1.40 (0.80 to 2.45) NS 2.06 (1.52 to 2.80) <0.0001 1.26 (0.78 to 2.03) NS
Altitude level (n=1275)
2500–3499 m Reference Reference Reference Reference
3500–4499 m 2.87 (2.07 to 3.97) <0.0001 3.31 (1.90 to 5.79) <0.0001 1.80 (1.40 to 2.33) <0.0001 2.10 (1.36 to 3.26) 0.0009
4500+ m 1.95 (1.22 to 3.13) 0.0055 2.81 (1.35 to 5.88) 0.006 0.82 (0.54 to 1.24) NS 1.60 (0.84 to 3.05) NS
Hypoxaemia
SpO2 <89% 1.81 (1.33 to 2.46) 0.0002 2.06 (1.29 to 3.29) 0.0027 1.42 (1.09 to 1.86) 0.0098 1.99 (1.32 to 2.99) 0.0010
Group according to Hb
Anaemia 1.44 (0.76 to 2.75) NS 0.92 (0.21 to 4.01) NS 1.17 (0.70 to 1.93) NS 0.83 (0.25 to 2.78) NS
Normal Reference Reference Reference Reference
Moderate
polycythaemia
2.50 (1.80 to 3.46) <0.0001 3.48 (2.03 to 5.95) <0.0001 1.98 (1.50 to 2.60) <0.0001 2.92 (1.86 to 4.60) <0.0001
Excessive
polycythaemia
3.67 (2.30 to 5.86) <0.0001 5.75 (2.97 to 11.14) <0.0001 2.44 (1.59 to 3.74) <0.0001 4.97 (2.77 to 8.94) <0.0001
DM, diabetes mellitus; BMI, body mass index; Hb, haemoglobin; HDL, high-density lipoprotein; NS, not significant; OGTT, oral glucose tolerance test; SpO2, oxyhaemoglobin saturation




























Table 7 Associations of high-altitude, hypoxaemia and polycythaemia with glucose intolerance adjusted for all other confounders by multiple logistic regression analysis
Fasting hyperglycaemia Fasting DM
Hyperglycaemia
(OGTT) DM (OGTT)
OR CI p Value OR CI p Value OR CI p Value OR CI p Value
Age (years)
40–49 Reference Reference Reference Reference
50–59 1.21 (0.77 to 1.91) NS 1.49 (0.73 to 3.06) NS 1.05 (0.73 to 1.52) NS 1.73 (0.91 to 3.30) 0.0951
60–69 2.03 (1.34 to 3.07) 0.0008 2.06 (1.06 to 4.02) 0.0336 1.73 (1.23 to 2.43) 0.0016 2.34 (1.28 to 4.27) 0.0057
70+ 1.36 (0.83 to 2.22) NS 1.38 (0.62 to 3.06) NS 1.79 (1.21 to 2.65) 0.0035 1.77 (0.89 to 3.54) NS
Male (vs female) 2.17 (1.57 to 2.99) <0.0001 2.5 (1.50 to 4.18) 0.0004 1.68 (1.29 to 2.18) 0.0001 1.95 (1.26 to 3.01) 0.0026
Overweight 1.68 (1.18 to 2.40) 0.0041 1.43 (0.82 to 2.52) NS 1.66 (1.25 to 2.21) 0.0004 1.46 (0.91 to 2.35) NS
Dyslipidaemia 1.59 (1.14 to 2.22) 0.0058 2.11 (1.26 to 3.54) 0.0048 1.38 (1.05 to 1.81) 0.023 2.51 (1.60 to 3.92) <0.0001
Hypertension 1.09 (0.78 to 1.50) NS 1.18 (0.71 to 1.96) NS 1.16 (0.88 to 1.51) NS 1.26 (0.82 to 1.95) NS
Livelihood
Farmer 6.62 (3.56 to 12.32) <0.0001 5.61 (1.90 to 16.55) 0.0018 3.83 (2.38 to 6.15) <0.0001 3.10 (1.40 to 6.86) 0.0051
Nomad Reference Reference Reference Reference
Urban dweller 2.53 (1.42 to 4.49) 0.0015 3.47 (1.28 to 9.42) 0.0145 2.66 (1.74 to 4.07) <0.0001 1.96 (0.96 to 3.99) 0.0641
Altitude level
2500–3499 m Reference Reference Reference Reference 1
3500–4499 m 2.07 (1.44 to 2.98) <0.0001 1.76 (0.94 to 3.28) 0.0767 1.23 (0.92 to 1.64) NS 1.08 (0.65 to 1.78) NS
4500+ m 3.59 (1.75 to 7.37) 0.0005 4.36 (1.33 to 14.31) 0.0150 1.25 (0.70 to 2.23) NS 1.46 (0.59 to 3.65) NS
Hypoxaemia
SpO2 <89% 1.48 (1.04 to 2.10) 0.0305 1.56 (0.92 to 2.65) 0.099 1.45 (1.07 to 1.97) 0.0183 1.72 (1.09 to 2.73) 0.0202
Group according to Hb
Anaemia 1.47 (0.75 to 2.89) NS 0.95 (0.21 to 4.24) NS 1.24 (0.74 to 2.08) NS 0.84 (0.25 to 2.89) NS
Normal Reference Reference Reference Reference
Moderate
polycythaemia
2.00 (1.39 to 2.87) 0.0002 2.57 (1.44 to 4.60) 0.0014 1.90 (1.40 to 2.58) <0.0001 2.34 (1.42 to 3.84) 0.0008
Excessive
polycythaemia
3.58 (2.11 to 6.06) <0.0001 5.46 (2.62 to 11.38) <0.0001 3.16 (1.94 to 5.15) <0.0001 5.35 (2.76 to 10.34) <0.0001




























shown even after adjustment of the effects of both life-
style and ethnicity in all participants, and also in a separ-
ate analysis of farmers and nomads, but not in urban
dwellers. Analysis of hypoxaemia, using SpO2, was
closely associated with a high prevalence of glucose
intolerance as measured by FBG and OGTT after adjust-
ment for both dwelling at high altitude and all
lifestyle-related health factors (ﬁgure 1).
Comparison with other studies on the association between
hypoxaemia and glucose intolerance
No previous reports have shown an association between
hypoxia and glucose intolerance in high-altitude
dwellers. However, there are some reports on the associ-
ation of hypoxaemia with glucose intolerance in lowlan-
ders58–63 and in animals.64 People with respiratory
diseases,58 sleep apnoea syndrome60 61 and insomnia,62 63
have a high prevalence of glucose intolerance. An iso-
lated high fasting glucose pattern in a glucose tolerance
test was dominant and insulin resistance increased in
these people.60–63 High-altitude dwellers have more
severe hypoxaemia during sleep than during waking
hours, and the prevalence of insomnia was higher in
people dwelling at higher altitudes. Aggravation of
insulin resistance in an acute hypoxic environment has
also been reported to be caused not only by an increase
in stress hormones, including epinephrine and cortico-
steroid, but also by the direct effect of hypoxia.59
Although there are no reports on humans showing
vulnerability to glucose intolerance in newborns from
mothers who have hypoxaemia, this has been reported in
calves (ﬁgure 1).64
In our previous study on lowlanders aged 40 years or
older in Tosa, Japan, the prevalence of HG (fasting HG)
and DM (fasting DM) was 46.2% (22.7%) and 16.7%
(6.8%), respectively.65 In that study, the percentages of
‘fasting HG in HG’ (‘fasting DM in DM’) were 49.1%
(40.7%). Those percentages were calculated using the
same data as in table 5 and they increased parallel with
altitude (2500–3499 vs 3500–4499 vs 4500 m). In
farmers, the percentages of ‘fasting HG in HG’ (‘fasting
DM in DM’) increased with elevation of altitude from
54.3% (45.8%) to 80.0% (100%), in nomads these per-
centages also increased from 38.8% (43.2%) to 50.0%
(40.4%) to 84.7% (92.7%), and in urban dwellers, these
percentages increased from 30.8% (59.2%) to 61.1%
(79.9%). The percentage of ‘fasting HG in HG’ in
farmers and urban dwellers exceeded 60–80% above
3500 m, and in nomads, exceeded 80% above 4500 m.
The 2 h-BG levels in our result in fasting IHG/fasting
DM were much lower (130.7/224.5 mg/dL) compared
with those in Tosa Town (172.4/ 262.6 mg/dL), though
FBG levels in our study of fasting IHG/fasting DM
(115.2/166.0 mg/dL) were not lower compared with
those in Tosa Town (115.8/146.2 mg/dL). These results
are compatible with the isolated high fasting glucose
pattern and increased insulin resistance in people who
have hypoxaemia and stress while sleeping.60–63
Our results and previous reports suggest that mild
hypoxia and a higher metabolic rate in participants
living at an altitude lower than 3500 m may be preventive
for glucose intolerance. However, moderate hypoxia and
dwelling at higher altitudes over 3500 m may increase
the risk of fasting glucose intolerance (ﬁgure 1).
Hypothesis of associations of polycythaemia, hypoxaemia
and glucose intolerance in high-altitude dwellers
An association between polycythaemia and glucose
intolerance in a small sample population has been previ-
ously reported.40 In our study of a large high-altitude
population, using multivariate analysis, after adjustment
for lifestyle-related factors and hypoxaemia, this associ-
ation was strong. As a result, we propose the following two
hypotheses to explain the mechanism of the strong asso-
ciations among polycythaemia, hypoxaemia and glucose
intolerance. The ﬁrst hypothesis is that polycythaemia
aggravates hypoxaemia and leads to glucose intolerance
(*1 and *2 in ﬁgure 1). This hypothesis was based on the
association of polycythaemia with hypoxaemia (table 5
and online supplementary table S1) and the association
of hypoxaemia with glucose intolerance (tables 6 and 7).
The cross-sectional design of our study is a limitation
to the causal relation. Additionally, there are no longitu-
dinal studies on highlanders. However, a previous longi-
tudinal report on lowlanders in a large 9-year follow-up
study supports our hypothesis in which the highest
haematocrit group (>44.3%) has a higher risk (OR=1.6)
Figure 1 Hypothesised associations of hypoxaemia,
polycythaemia and glucose intolerance with the influence of
ageing and lifestyle change. Hypothesis 1 (*1 and *2) and
hypothesis 2 (*3 and *4) in the association of hypoxia,
polycythaemia and glucose intolerance. Ageing and lifestyle
change accelerate the association, ‘Diabetes acceleration
hypothesis’. *1 or 4: Proposed according to online
supplementary table S1 and table 5. *2 or 3: Proposed
according to data in tables 6 and 7, online supplementary
table S1, and previous studies.58–64 *1 and *2: Proposed
according to a previous study.66 *3 and *4: Proposed
according to previous studies.76 77 *5: Proposed according to
table 3. *6: Proposed according to our data compared with a
previous study.74 *7: Proposed according to online
supplementary table S1.
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of diabetes onset compared with the lowest group
(<39.0%).66 The mechanism of this association is specu-
lated as follows: lower blood circulation caused by the
high viscosity of polycythaemia is considered to disrupt
the transport of insulin, glucose and oxygen to tissue
cells, resulting in low cellular intake of glucose and
lower activity of respiration, which requires oxygen and
glucose in cells.66 Our study showed an association of
anaemia with HG.67 This supports our ﬁrst hypothesis
because anaemia results in low activity of O2 transport
and subsequent hypoxaemia in tissue, which is aggra-
vated at high altitude. Almost all study participants with
anaemia had iron deﬁciency.67 Also, Ladakhi farmers
eat less meat than Tibetan nomads do,33 68 and are vul-
nerable to suffering from iron deﬁciency anaemia.
Polycythaemia may be a sign of maladaptation to
hypoxia, which leads to glucose intolerance, because
Tibetan people have acquired a hypoxic adaptation by
preventing polycythaemia through a genetic response to
hypoxia.20 21 69–73 Tibetans (mean age 34–35 years, BMI
18.4–18.5) compared with Andean highlanders (mean
age 37–38 years, BMI 22.3–23.4) living at similar alti-
tudes (4000 m) have lower Hb levels (male/female:
15.6/14.2 vs 19.1/17.8 g/dL, respectively), though parti-
cipants with anaemia were excluded from this study.74
The genes responsible for lower Hb are PPARA, EGLN1
and EPAS1, and the mean Hb of both sexes is decreased
by these advantageous haplotypes.70 The frequency of
the adaptive haplotype of EPAS1 is reported to be 87%
in Tibetans and 9% in Han Chinese.71 The sex-adjusted
Hb level is 0.8 g/dL lower in homozygotes compared
with heterozygotes of EPAS1.69
Mean Hb in our older participants (mean 58.3 years,
BMI 24.0–25.1, altitude 2900–4800 m, anaemia was
excluded) was 16.1 g/dL (male/female: 17.2/15.1),
which was 1.6/0.9 g/dL higher compared with the
younger Tibetans (34–35 years).74 Excluding overweight
participants from the older group, the mean Hb of
these older participants was 1.4/0.6 g/dL (male/
female) higher compared with that of the younger parti-
cipants.74 Another report showed the associations
between age, polycythaemia and the genes that have
adapted to hypoxia. Older Tibetan chronic mountain
sickness patients (mean age 54 years, n=45) have as
much as 96% of the adaptive haplotype EPAS1 com-
pared with 72% in younger people without polycythae-
mia (mean age: 30 years, n=34).75 Ageing may aggravate
not only hypoxaemia (table 3) but also polycythaemia in
Tibetan people (*5 and *6 in ﬁgure 1), even in those
with adaptive haplotypes.75
Hypothesis of associations of glucose intolerance,
hypoxaemia and polycythaemia in high-altitude dwellers
Our second hypothesis is that glucose intolerance leads
to microvascular complications and aggravation of tissue
hypoxaemia. Polycythaemia is enhanced with compensa-
tion for this hypoxaemia (*3 and *4 in ﬁgure 1). The
basis of our results for this hypothesis is the same as in
the ﬁrst hypothesis because it was a cross-sectional study
without causal relation. However, there are observational
studies in lowlanders supporting this hypothesis.76 77
Infants have complications of polycythaemia from
mothers with diabetes. Chronic intrauterine hypoxaemia
intermediates this association.76 77
The advantageous homozygotes of the genes that are
involved in adaptation to hypoxia (EGLN1 and PPARA)
have stronger metabolic effects to facilitate anaerobic
glycolysis and regression of lipid catabolism, resulting in
higher serum concentrations of lipids by adaptation to
hypoxia.70 78 79 This effect may prevent the development
of diabetes in younger people with a traditional lifestyle.
However, sedentary workers and elderly people with
advantageous genetic adaptations to hypoxia may be vul-
nerable to obesity, hyperlipidaemia and increased
insulin resistance by lifestyle changes compared with
people without these advantageous genes. Obesity and
dyslipidaemia lead not only to increased insulin resist-
ance (tables 6 and 7), but also to hypoxaemia (see
online supplementary table S1 and *7 in ﬁgure 1).
Higher Hb was found in participants in Jiegu
Town who were overweight compared with those not
overweight. This difference in Hb (male/female
1.3/0.9 g/dL) was higher than the difference of the sex-
adjusted Hb (0.8 g/dL) in homozygotes compared with
heterozygotes of EPAS1.69 The effect of lifestyle changes
on polycythaemia in our study overcame the acquired
hypoxic adaptation for prevention of polycythaemia.
People in Jiegu Town (3700 m) with a high prevalence of
overweight also had the highest prevalence of HG and
fasting HG. Those parameters were accelerated both by
lifestyle changes and by hypoxaemia, with an extremely
high frequency of polycythaemia. While people in the
higher altitude community of Domkhar (3800 m) had a
low prevalence of overweight, they had a high prevalence
of HG with an especially high fasting HG and polycythae-
mia, which may be accelerated mainly by hypoxia.
Our ﬁrst hypothesis mainly explains our result of the
association of dwelling at high altitude or hypoxaemia
with an increase in glucose intolerance as seen in
Domkhar. The second hypothesis is mainly associated
with our result of lifestyle-related factors leading to an
increase in glucose intolerance. According to our results
and previous reports, these two hypotheses may be acting
simultaneously with each other, considering the close
associations among hypoxaemia, polycythaemia and
glucose intolerance as seen in Jiegu Town. The associ-
ation of glucose intolerance with polycythaemia and hyp-
oxaemia is accelerated by ageing and lifestyle changes,
and there may be the vulnerability of the hypoxia adap-
tive genes for glucose intolerance as the background,
called the ‘Diabetes acceleration hypothesis’ (ﬁgure 1).
Conclusions, unanswered questions and policy
implications
Socioeconomic factors and hypoxia—the effect of alti-
tudes over 3500 m—play major roles in the prevalence
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of glucose intolerance in highlanders. Hypoxaemia and
polycythaemia were closely associated with glucose
intolerance after adjustment for the effects of lifestyle
changes in our study. Tibetan people may be vulnerable
to glucose intolerance, with polycythaemia as a sign of
poor hypoxic adaptation. However, the mechanism of
the onset of glucose intolerance by hypoxaemia in high-
altitude dwellers is unknown. A previous report showed
higher oxidative stress in Tibetan people compared with
in Han people, and higher oxidative stress was associated
with glucose intolerance and arteriosclerosis.80 81
Further examination of the metabolic mechanism and
oxidative stress in association with the effects of genes
involved in hypoxia adaptation in high-altitude dwellers
is needed. Because the matter of whether the WHO cri-
teria of glucose intolerance can be applicable in high-
altitude people has not been established, the prognosis
of fasting HG and HG associated with high-altitude
should be examined longitudinally. Prevention of
lifestyle-related diseases and health education should be
advocated, especially in high altitude dwellers, with
rapidly prevailing socioeconomic globalisation.
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